Management and Follow-up of Patients with a Bronchial Neuroendocrine Tumor in the Last Twenty Years in Ireland: Expected Inconsistencies and Unexpected Discoveries

Table 3

Therapeutic management of bronchial NET patients diagnosed, treated, or followed-up at our institution from 1^st January 1995 to 31^st December 2015 (). One patient underwent both radiotherapy and chemotherapy.

Treatment	Number of patients (%)
Surgery	44 (95.6%)
Somatostatin analogs	0 (0%)
Interferon alpha	0 (0%)
Peptide receptor radionuclide therapy	0 (0%)
Radiotherapy	1 (2.2%)
Chemotherapy	1 (2.2%)
Locoregional therapy of distant metastases (radiofrequency ablation, chemoembolization)	0 (0%)
No treatment	1 (2.2%)

: number of patients.